Mindray Medical International (NYSE: MR) and Derma Sciences (NASDAQ:DSCI) are both healthcare companies, but which is the better business? We will contrast the two businesses based on the strength of their analyst recommendations, earnings, dividends, valuation, institutional ownership, profitability and risk.
Earnings and Valuation
This table compares Mindray Medical International and Derma Sciences’ revenue, earnings per share and valuation.
|Gross Revenue||Price/Sales Ratio||Net Income||Earnings Per Share||Price/Earnings Ratio|
|Mindray Medical International||N/A||N/A||N/A||$1.49||18.75|
This table compares Mindray Medical International and Derma Sciences’ net margins, return on equity and return on assets.
|Net Margins||Return on Equity||Return on Assets|
|Mindray Medical International||15.93%||12.70%||8.37%|
Mindray Medical International pays an annual dividend of $0.36 per share and has a dividend yield of 1.3%. Derma Sciences does not pay a dividend. Mindray Medical International pays out 24.2% of its earnings in the form of a dividend.
Institutional & Insider Ownership
58.9% of Derma Sciences shares are owned by institutional investors. 9.9% of Derma Sciences shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.
This is a summary of current ratings for Mindray Medical International and Derma Sciences, as provided by MarketBeat.com.
|Sell Ratings||Hold Ratings||Buy Ratings||Strong Buy Ratings||Rating Score|
|Mindray Medical International||0||0||0||0||N/A|
Mindray Medical International beats Derma Sciences on 6 of the 9 factors compared between the two stocks.
About Mindray Medical International
Mindray Medical International Limited is a developer, manufacturer and marketer of medical devices across the world. The Company operates in three segments: patient monitoring and life support products, in-vitro diagnostic products and medical imaging systems. Its patient monitoring devices track the physiological parameters of patients, such as heart rate, blood pressure, respiration and temperature. It offers patient monitoring devices that are suitable for adult, pediatric and neonatal patients and are used principally in hospital intensive care units, operating rooms and emergency rooms. Its life support products provide operation room or intensive care unit solutions for the end users in the operating room. Its in-vitro diagnostic products provide data and analysis on blood, urine and other bodily fluid samples for clinical diagnosis and treatment. Its medical imaging systems segment includes ultrasound systems, digital radiography systems and a magnetic resonance imaging system.
About Derma Sciences
Derma Sciences, Inc. (Derma Sciences) is a medical device company. The Company operates through two segments: advanced wound care and traditional wound care products. Advanced wound care products principally consist of both novel and otherwise differentiated dressings, devices and skin substitutes designed to promote wound healing and/or prevent infection. The Company’s advanced wound care product line consists of MEDIHONEY, TCC-EZ, AMNIOEXCEL and AMNIOMATRIX, XTRASORB and BIOGUARD. Traditional wound care products principally consist of commodity related dressings, ointments, gauze bandages, adhesive bandages, wound closure strips, catheter fasteners and skin care products. The Company’s traditional wound care product line includes branded gauze sponges and bandages, non-adherent impregnated dressings, retention devices, paste bandages and other compression devices for the medical markets.
Receive News & Ratings for Mindray Medical International Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mindray Medical International and related companies with MarketBeat.com's FREE daily email newsletter.